Article
Epigenetic pathways and plasticity in brain tumors
30 Aug 2020
Abstract excerpt
Clinical studies have shown that treating many primary brain tumors is challenging due in part to the lack of safe and effective compounds that cross the blood brain barrier (BBB) (Tan et al., 2018). However, if we were to imagine that we have ideal BBB penetrant compounds that target brain tumor cells selectively, recent studies suggest that those compounds may still not be effective due to the heterogenous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
